Evidence Hub

Inhaled iloprost improves gas exchange in patients with COVID-19 and acute respiratory distress syndrome

N. Tsareva, S. Avdeev, D. Kosanovic, R. Schermuly, N. Trushenko, G. Nekludova

Critical Care, 2021

22 participants · 9 citations

Abstract

© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. To the Editor, Severe acute respiratory syndrome coronavirus (SARSCoV)-2 outbreak that began in 2019 and spread rapidly across the world has been demonstrated to cause viral pneumonia, acute respiratory distress syndrome (ARDS) and multi-organ system failure [1]. Given the lack of scientific data, efforts are focused on an empirical search for therapeutic strategies to ensure the adequate gas…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free